travel
Commented by Fabian Lorenz on April 10th, 2024 | 07:00 CEST
BASF and Cardiol Therapeutics recommended to buy! TUI share with momentum!
BASF shares have gained over 30% within six months. But is the rally in BASF shares slowly running out of steam? The fact that the share did not rise sharply yesterday despite a significant price target increase suggests this is the case. Many experts see little potential for further price increases. The situation is different for the biotech company Cardiol Therapeutics. The analysts at Canaccord believe that the shares of the specialist in cardiovascular diseases could perform by around 200%. Financing is secured until 2026, and important study data is due in the current quarter. The TUI share has been on a roll for several months now. Will the share continue to rise with the increase in temperatures? Management is certainly optimistic about the future.
Read
Commented by Armin Schulz on March 28th, 2024 | 08:45 CET
TUI, dynaCERT, Evotec - The profit is in buying
In the world of the financial markets, the timeless maxim applies: "The profit is in buying". This tried and tested stock market adage, which may seem trivial at first glance, is actually the key to financial success. Indeed, the price at which an investment is purchased often determines its subsequent triumph or failure long before the sale is even considered. Despite advances in technology and the complexity of markets, the basic lesson remains - buying wisely and at a well-considered price lays the foundation for profits. We have picked out three interesting candidates.
Read
Commented by Fabian Lorenz on March 27th, 2024 | 08:45 CET
Shares in Focus: TUI, Rheinmetall, and Defense Metals with good reasons for price increases
The TUI share was one of the top performers on the German stock market yesterday. The EUR 7 mark was exceeded, making things exciting on the chart. Analysts expect significantly higher prices for the tourism group. Rheinmetall shares are among the top performers of the year. An end to the price increase is not in sight. The armaments group has announced a new order worth billions. The manufacture of armaments, aircraft, cruise ships and numerous other high-tech products would not be possible without rare earths. However, most of these come from China and Russia. This makes the Defense Metals share interesting. The Company is making great strides with its rare earths project in Canada. The share should also benefit from this progress.
Read
Commented by André Will-Laudien on March 20th, 2024 | 07:30 CET
Entry prices or Sell? BioNTech, Defence Therapeutics, Lufthansa and Nvidia in focus
The stock market keeps running and running - but in reality, it is just a handful of stocks that make waves every day. Investors should now be vigilant because, like the recent correction in Bitcoin, the major indices could also fall by 10%. Of course, nobody is thinking about this at the moment; the mood is too good, almost euphoric, considering Germany's precarious economic situation. We analyze technical trends and fundamental assessments to ensure everything in your portfolio goes smoothly. In our view, BioNTech, Defence Therapeutics, and Lufthansa are on the runway, but when it comes to Nvidia, you should start deploying the parachute slowly. What is next here?
Read
Commented by Fabian Lorenz on March 7th, 2024 | 06:45 CET
Buy recommendations for TUI and Saturn Oil + Gas share - Aixtron share price targets tumble
TUI was among the daily winners yesterday. The tourism group's share price rose by more than 5%. The reason was positive analyst commentary. The price target was raised, providing significant upside potential from the current level. Experts also recommend buying Saturn Oil & Gas. After a successful capital increase, the target price for the oil producer's shares was raised. Analysts see over 100% upside potential and scope for high dividends. At Aixtron, analysts' price targets are tumbling. There is even a sell recommendation. However, not all analysts are pessimistic; some see an opportunity in the price slide of the past few days.
Read
Commented by Stefan Feulner on February 14th, 2024 | 07:15 CET
TUI, Royal Helium, thyssenkrupp nucera - Significant increases create room for improvement
The reporting season for the full year 2023 has already passed its peak and is entering its final phase this week. Many companies were able to defy the weakening economic environment, delivering positive surprises in both the publication of the figures for the past financial year and in the forecasts for 2024. Tourism stocks, in particular, which have weakened in recent months, could experience a rebound as a result. Following the correction, analysts also see considerable potential in companies from the renewable energy sector.
Read
Commented by Armin Schulz on February 13th, 2024 | 07:00 CET
TUI, Globex Mining, Palantir - Movement is possible here
Investors should have TUI, Globex Mining and Palantir on their watchlist, as they could be on the verge of movement. While TUI, as a leading tourism company, is showing signs of recovery after the pandemic, Globex Mining promises important impetus for the future of the industry and green technologies with its broad commodities portfolio. Palantir, on the other hand, known for its advanced data analytics platforms, is on the brink of significant growth opportunities in an increasingly data-rich era. In this context, movements are possible, and as an investor, one would want to be invested early. We highlight the potential of the three companies.
Read
Commented by Fabian Lorenz on February 1st, 2024 | 07:30 CET
Top news: Plug Power, TUI, Prospera Energy
Should one buy Plug Power shares anti-cyclically now? Following the slump in the share price and the announced capital increase, more and more analysts are switching towards the bearish camp regarding the hydrogen pioneer. Has the bottom been reached? Prospera Energy shares have upside potential. The Canadian oil producer has met its targets for 2023, production is expected to increase significantly again in 2024, and the oil price is on the rise again. The share is, therefore, ripe for a turnaround. The TUI share has achieved this in the last few months of 2023. The share is currently consolidating. TUI is poised for a positive travel season in 2024 and aims to become more environmentally friendly.
Read
Commented by Fabian Lorenz on January 11th, 2024 | 07:00 CET
Evotec is in the analyst check, Tui with Wanderlust, and another 100% gain for Manuka Resources?
The Evotec stock is currently not for the faint-hearted. After the resignation of the long-serving board member caused uncertainty, the biotech company was able to reassure investors with a milestone payment. Analysts are speaking out and expressing their opinions, and a real "bull" is among them. And what about Manuka Resources? At the beginning of December, news about an exciting project for battery metals caused a jump in the share price. Is it now worth getting in after the consolidation? The Tui share has also recently consolidated after a 50% gain within a few weeks. Analysts' price targets for the tourism company's shares vary widely. Hold or buy?
Read
Commented by André Will-Laudien on January 3rd, 2024 | 07:00 CET
Donald Trump turns 2024 into a false start - This is where the action is: TUI, Lufthansa, Desert Gold and Alibaba
"If I do not become president, the stock market is in for a bigger crash than the Great Depression of 1929," proclaimed Donald Trump, the former president and Republican aspirant, at the end of the year. The assessment makes for amusing and entertaining reading and contains an important message. The economy is sluggish, war is raging in many places, and inflation is galloping. Why are stocks still trading near their all-time highs? It is the interest rate fantasy because between 4 and 7 interest rate cuts by the ECB and the Fed are expected in 2024. This will allow countries to continue their bloated and debt-financed budgets, but it will not create prosperity in the long run. Despite Trump's gloomy forecast, we look at some interesting turnaround stocks.
Read